GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Cyclically Adjusted Revenue per Share

Medipost Co (XKRX:078160) Cyclically Adjusted Revenue per Share : ₩2,769.60 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medipost Co's adjusted revenue per share for the three months ended in Dec. 2023 was ₩499.803. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩2,769.60 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Medipost Co's average Cyclically Adjusted Revenue Growth Rate was 3.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medipost Co was 6.60% per year. The lowest was 4.70% per year. And the median was 6.10% per year.

As of today (2024-05-14), Medipost Co's current stock price is ₩6880.00. Medipost Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₩2,769.60. Medipost Co's Cyclically Adjusted PS Ratio of today is 2.48.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipost Co was 31.22. The lowest was 2.44. And the median was 11.08.


Medipost Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Medipost Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Cyclically Adjusted Revenue per Share Chart

Medipost Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,274.57 2,413.37 2,535.33 2,671.05 2,769.60

Medipost Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,671.05 2,729.71 2,761.76 2,826.95 2,769.60

Competitive Comparison of Medipost Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Medipost Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medipost Co's Cyclically Adjusted PS Ratio falls into.



Medipost Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medipost Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=499.803/118.8477*118.8477
=499.803

Current CPI (Dec. 2023) = 118.8477.

Medipost Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 468.642 99.253 561.162
201406 526.251 99.353 629.510
201409 563.062 99.608 671.820
201412 917.651 99.098 1,100.534
201503 615.120 99.720 733.109
201506 624.524 100.050 741.861
201509 516.164 100.110 612.775
201512 429.779 100.220 509.661
201603 442.602 100.560 523.093
201606 392.402 100.790 462.705
201609 368.680 101.460 431.863
201612 380.619 101.560 445.409
201703 534.120 102.850 617.199
201706 670.030 102.610 776.060
201709 515.188 103.490 591.641
201712 623.452 102.990 719.447
201803 639.173 104.100 729.724
201806 299.859 104.130 342.241
201809 305.470 105.650 343.629
201812 305.504 104.350 347.949
201903 795.455 104.490 904.756
201906 631.448 104.880 715.543
201909 617.617 105.200 697.741
201912 608.756 105.120 688.254
202003 679.860 105.540 765.585
202006 659.053 104.870 746.896
202009 657.663 106.200 735.986
202012 699.576 105.765 786.108
202103 709.206 107.357 785.113
202106 727.952 107.579 804.207
202109 779.752 108.759 852.082
202112 822.391 109.676 891.161
202203 819.285 111.806 870.886
202206 850.378 114.083 885.896
202209 870.819 114.831 901.277
202212 547.931 115.200 565.280
202303 935.021 116.550 953.458
202306 888.244 117.140 901.194
202309 855.237 119.111 853.345
202312 499.803 118.848 499.803

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Medipost Co  (XKRX:078160) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medipost Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6880.00/2769.6
=2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipost Co was 31.22. The lowest was 2.44. And the median was 11.08.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medipost Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Medipost Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (XKRX:078160) Business Description

Industry
Traded in Other Exchanges
N/A
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines